Ironwood医药

IRWD NASDAQ
10.36
+0.08
+0.78%
交易中 10:16 06/25 EDT
开盘
10.35
昨收
10.28
最高
10.52
最低
10.20
成交量
10.55万
成交均量(3M)
137.13万
52周最高
17.74
52周最低
7.59
换手率
0.07%
市值
16.12亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Ironwood医药 IRWD股票价格,Ironwood医药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Ironwood Pharmaceuticals, Inc. is a biotechnology company. The Company is advancing product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS C), and chronic idiopathic constipation (CIC), hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease (uncontrolled GERD), and vascular and fibrotic diseases. It operates in human therapeutics business segment. Its product, linaclotide, is available to adult men and women suffering from IBS C or CIC in the United States under the trademarked name LINZESS, and is available to adult men and women suffering from IBS C in certain European countries under the trademarked name CONSTELLA. It is also advancing IW-3718, a gastric retentive formulation of a bile acid sequestrant with the potential to provide symptomatic relief in patients with uncontrolled GERD. Its vascular/fibrotic programs include IW-1973 and IW-1701, which targets soluble guanylate cyclase (sGC).
展开 >

最近浏览

名称
价格
涨跌幅